Peptonic Medical AB (publ) (“Peptonic” completes comprehensive restructuring

In the first quarter of 2025, Peptonic commenced in‑court restructuring proceedings to address its financial distress and to ensure the viability of its business. The court appointed Jonas Premfors, DLA Piper, as administrator, and Mark Falkner, Eversheds Sutherland, remained as Peptonic’s legal advisor focusing on equity capital markets (ECM) matters.

Peptonic is a Swedish innovative biomedical company that conducts research, development and sales of medical treatments and lifestyle products in the field of women’s health. While the Nordics represent the main market for Peptonic, the United States is a key market, and the tariffs announced on “Liberation Day” worsened the financial position and the cross‑border business operations within the group. A key measure was then to make available a debtor‑in‑possession facility (“DIP facility”) in addition to the bridge loan facilities that had been made available prior to the restructuring, and to arrange for a rights issue to raise capital. Peptonic also managed to enter into a strategic distribution agreement with JoyLux for the United States, Canada, Mexico, and the United Kingdom.

Peptonic brought forward a comprehensive restructuring plan. The key measures included a 30 percent composition payment in cash without instalments to unsecured creditors, debt‑equity swaps with respect to the bridge loan facilities and the DIP facility, and a rights issue of units consisting of shares and warrants based on a prospectus. To safeguard the interests of both the creditors and the investors, the rights issue and the debt‑equity swaps were made conditional upon the approval of the debt settlement in the restructuring plan, and vice versa.

In the fourth quarter of 2025, the court adopted the restructuring plan by way of a cross‑class cramdown, and the restructuring plan subsequently gained legal force. In the first quarter of 2026, the rights issue was completed, and the creditors then received the composition payment.

Link to press release: Peptonic Medical AB’s Reconstruction plan becomes legally binding and the reconstruction is concluded – Peptonic Medical